Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al

P Dubsky; G Curigliano; H J Burstein; E P Winer; M Gnant; S Loibl; M Colleoni; M M Regan; M Piccart-Gebhart; H-J Senn; B Thürlimann; Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; F André; J Baselga; J Bergh; H Bonnefoi; S Y Brucker; F Cardoso; L Carey; E Ciruelos; J Cuzick; C Denkert; A Di Leo; B Ejlertsen; P Francis; V Galimberti; J Garber; B Gulluoglu; P Goodwin; N Harbeck; D F Hayes; C-S Huang; J Huober; H Khaled; J Jassem; Z Jiang; P Karlsson; M Morrow; R Orecchia; K C Osborne; O Pagani; A H Partridge; K Pritchard; J Ro; E J T Rutgers; F Sedlmayer; V Semiglazov; Z Shao; I Smith; M Toi; A Tutt; G Viale; T Watanabe; T J Whelan; B Xu

doi:10.1093/annonc/mdx543

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al

Ann Oncol. 2018 Jan 1;29(1):281-282. doi: 10.1093/annonc/mdx543.

Authors

P Dubsky^{1

2}, G Curigliano³, H J Burstein⁴, E P Winer⁴, M Gnant¹, S Loibl⁵, M Colleoni³, M M Regan⁶, M Piccart-Gebhart⁷, H-J Senn⁸, B Thürlimann⁹; Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017; F André¹⁰, J Baselga¹¹, J Bergh¹², H Bonnefoi¹³, S Y Brucker¹⁴, F Cardoso¹⁵, L Carey¹⁶, E Ciruelos¹⁷, J Cuzick¹⁸, C Denkert¹⁹, A Di Leo²⁰, B Ejlertsen²¹, P Francis²², V Galimberti¹, J Garber², B Gulluoglu²³, P Goodwin²⁴, N Harbeck²⁵, D F Hayes²⁶, C-S Huang²⁷, J Huober²⁸, H Khaled²⁹, J Jassem³⁰, Z Jiang³¹, P Karlsson³², M Morrow¹¹, R Orecchia¹, K C Osborne³³, O Pagani³⁴, A H Partridge², K Pritchard³⁵, J Ro³⁶, E J T Rutgers³⁷, F Sedlmayer³⁸, V Semiglazov³⁹, Z Shao⁴⁰, I Smith⁴¹, M Toi⁴², A Tutt⁴³, G Viale^{44

45}, T Watanabe⁴⁶, T J Whelan⁴⁷, B Xu⁴⁸

Affiliations

¹ Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
² Klinik St. Anna, Luzern, Switzerland.
³ Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy.
⁴ Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
⁵ German Breast Group, Neu-Isenburg, Germany.
⁶ Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
⁷ Institut Jules Bordet, Bruxelles, Belgium.
⁸ Tumor and Breast Center ZeTuP, St Gallen, Switzerland.
⁹ Breast Center, Kantonsspital St. Gallen, St Gallen, Switzerland.
¹⁰ Institut de Cancérologie Gustave Roussy, Villejuif, France.
¹¹ Memorial Sloan Kettering Cancer Center, New York, USA.
¹² Karolinska Institute and University Hospital, Stockholm, Sweden.
¹³ University of Bordeaux, Bordeaux, France.
¹⁴ Universitäts-Frauenklinik Tübingen, Tübingen, Germany.
¹⁵ Champalimaud Cancer Centre, Lisbon, Portugal.
¹⁶ Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
¹⁷ Hospital Universitario 12 de Octubre, Madrid, Spain.
¹⁸ Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
¹⁹ Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
²⁰ Azienda Usl Toscana Centro, Prato, Italy.
²¹ Rigshospitalet, Copenhagen, Denmark.
²² Peter McCallum Cancer Centre, Melbourne, Australia.
²³ Marmara University School of Medicine, Istanbul, Turkey.
²⁴ University of Toronto, Mount Sinai Hospital, Toronto, Canada.
²⁵ University of Munich, München, Germany.
²⁶ Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA.
²⁷ National Taiwan University Hospital, Taipei, Taiwan.
²⁸ University of Ulm, Ulm, Germany.
²⁹ The National Cancer Institute, Cairo University, Cairo, Egypt.
³⁰ Medical University of Gdansk, Gdansk, Poland.
³¹ Hospital Affiliated to Military Medical Science, Beijing, China.
³² Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden.
³³ Baylor College of Medicine, Houston, USA.
³⁴ Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
³⁵ University of Toronto, Sunnybrook Odette Cancer Center, Toronto, Canada.
³⁶ National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea.
³⁷ Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
³⁸ LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria.
³⁹ N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation.
⁴⁰ Fudan University Cancer Hospital, Shanghai, China.
⁴¹ The Royal Marsden, Sutton, Surrey, UK.
⁴² Graduate School of Medicine Kyoto University, Sakyo-ku Kyoto City, Japan.
⁴³ Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.
⁴⁴ University of Milan, Milan, Italy.
⁴⁵ Istituto Europeo di Oncologia, Milan, Italy.
⁴⁶ Hamamatsu Oncology Center, Hamamatsu, Japan.
⁴⁷ McMaster University, Hamilton, Canada.
⁴⁸ National Cancer Center, Chaoyang District, Beijing, China.

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms
Consensus*
Humans
Radiation Oncology*

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States